Imunon, Inc. — Director's Dealing 2011

Mar 23, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-03-23

Reporting Person: Borys Nicholas (CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-03-23	Celsion Corporation Common Stock	C	2500	$2.4	Acquired	30687	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-03-23	Series A 8% Redeemable Convertible Preferred Stock	$2.4	C	6	Disposed	2013-01-14	Celsion Corporation Common Stock (2500)	Direct

Footnotes

F1: Shares of Series A 8% Redeemable Convertible Preferred Stock with a stated value of $1,000 per share were converted to shares of Celsion Corporation Common Stock at a fixed conversion price of $2.40 per common stock.